Nov 24 (Reuters) - Alvotech SA ALVO.O:
ALVOTECH ANNOUNCES APPROVAL OF AVT03, A BIOSIMILAR TO PROLIA® AND XGEVA® (DENOSUMAB) IN THE EUROPEAN ECONOMIC AREA
Source text: ID:nGNX63nPZ3
Further company coverage: ALVO.O
((Reuters.Briefs@thomsonreuters.com;))